MedPath
NMPA Approval

Mixed Protamine Recombinant Human Insulin Injection(30R)

S20201006

February 5, 2020

H20160215

Drug Information

精蛋白重组人胰岛素混合注射液(30/70)

诺和灵30R

注射剂

3ml:300国际单位(笔芯)

生物制品

February 5, 2020

April 13, 2021

Company Information

Applicant Company

Novo Alle, DK-2880 Bagsvaerd, Denmark

Manufacturing Company

3612 Powhatan Road, Clayton, North Carolina 27527, U.S.A.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

精蛋白重组人胰岛素混合注射液(30/70) - NMPA 批准文号 | MedPath